Sporadic  ||| S:0 E:9 ||| NNP
and  ||| S:9 E:13 ||| CC
hereditary  ||| S:13 E:24 ||| JJ
primary  ||| S:24 E:32 ||| JJ
hyperparathyroidism  ||| S:32 E:52 ||| JJ
Primary  ||| S:52 E:60 ||| JJ
hyperparathyroidism  ||| S:60 E:80 ||| NNS
( ||| S:80 E:81 ||| -LRB-
PHPT ||| S:81 E:85 ||| NNP
)  ||| S:85 E:87 ||| -RRB-
is  ||| S:87 E:90 ||| VBZ
a  ||| S:90 E:92 ||| DT
common  ||| S:92 E:99 ||| JJ
endocrine  ||| S:99 E:109 ||| JJ
disorder ||| S:109 E:117 ||| NN
,  ||| S:117 E:119 ||| ,
particularly  ||| S:119 E:132 ||| RB
frequent  ||| S:132 E:141 ||| JJ
in  ||| S:141 E:144 ||| IN
post-menopausal  ||| S:144 E:160 ||| JJ
women ||| S:160 E:165 ||| NNS
.  ||| S:165 E:167 ||| .
It  ||| S:167 E:170 ||| PRP
is  ||| S:170 E:173 ||| VBZ
characterized  ||| S:173 E:187 ||| VBN
by  ||| S:187 E:190 ||| IN
hypercalcemia  ||| S:190 E:204 ||| NN
with  ||| S:204 E:209 ||| IN
inappropriately  ||| S:209 E:225 ||| RB
high  ||| S:225 E:230 ||| JJ
spontaneous  ||| S:230 E:242 ||| FW
plasma  ||| S:242 E:249 ||| FW
PTH ||| S:249 E:252 ||| FW
.  ||| S:252 E:254 ||| .
Singlegland  ||| S:254 E:266 ||| JJ
adenoma  ||| S:266 E:274 ||| NN
is  ||| S:274 E:277 ||| VBZ
the  ||| S:277 E:281 ||| DT
most  ||| S:281 E:286 ||| RBS
common  ||| S:286 E:293 ||| JJ
cause  ||| S:293 E:299 ||| NN
( ||| S:299 E:300 ||| -LRB-
75-  ||| S:300 E:304 ||| CD
85 ||| S:304 E:306 ||| CD
% ||| S:306 E:307 ||| NN
) ||| S:307 E:308 ||| -RRB-
.  ||| S:308 E:310 ||| .
PHPT  ||| S:310 E:315 ||| NNP
is  ||| S:315 E:318 ||| VBZ
usually  ||| S:318 E:326 ||| RB
a  ||| S:326 E:328 ||| DT
sporadic  ||| S:328 E:337 ||| JJ
disease  ||| S:337 E:345 ||| NN
but  ||| S:345 E:349 ||| CC
in  ||| S:349 E:352 ||| IN
approximately  ||| S:352 E:366 ||| RB
< ||| S:366 E:367 ||| SYM
5 ||| S:367 E:368 ||| CD
%  ||| S:368 E:370 ||| NN
of  ||| S:370 E:373 ||| IN
cases ||| S:373 E:378 ||| NNS
,  ||| S:378 E:380 ||| ,
a  ||| S:380 E:382 ||| DT
familial  ||| S:382 E:391 ||| JJ
hyperparathyroid  ||| S:391 E:408 ||| JJ
syndrome  ||| S:408 E:417 ||| NN
is  ||| S:417 E:420 ||| VBZ
diagnosed ||| S:420 E:429 ||| VBN
.  ||| S:429 E:431 ||| .
Familial  ||| S:431 E:440 ||| JJ
hyperparathyroidism  ||| S:440 E:460 ||| NN
is  ||| S:460 E:463 ||| VBZ
a  ||| S:463 E:465 ||| DT
clinically  ||| S:465 E:476 ||| NN
and  ||| S:476 E:480 ||| CC
genetically  ||| S:480 E:492 ||| RB
heterogeneous  ||| S:492 E:506 ||| JJ
group  ||| S:506 E:512 ||| NN
of  ||| S:512 E:515 ||| IN
disorders  ||| S:515 E:525 ||| NNS
including ||| S:525 E:534 ||| VBG
:  ||| S:534 E:536 ||| :
multiple  ||| S:536 E:545 ||| FW
endocrine  ||| S:545 E:555 ||| FW
neoplasia  ||| S:555 E:565 ||| FW
( ||| S:565 E:566 ||| -LRB-
MEN ||| S:566 E:569 ||| NNP
)  ||| S:569 E:571 ||| -RRB-
type  ||| S:571 E:576 ||| NN
1 ||| S:576 E:577 ||| CD
,  ||| S:577 E:579 ||| ,
MEN  ||| S:579 E:583 ||| NNP
type  ||| S:583 E:588 ||| NN
2A ||| S:588 E:590 ||| NN
,  ||| S:590 E:592 ||| ,
MEN4 ||| S:592 E:596 ||| NNP
,  ||| S:596 E:598 ||| ,
benign  ||| S:598 E:605 ||| FW
familial  ||| S:605 E:614 ||| FW
hypocalciuric  ||| S:614 E:628 ||| FW
hypercalcemia ||| S:628 E:641 ||| FW
,  ||| S:641 E:643 ||| ,
neonatal  ||| S:643 E:652 ||| JJ
severe  ||| S:652 E:659 ||| JJ
hyperparathyroidism ||| S:659 E:678 ||| NN
,  ||| S:678 E:680 ||| ,
hyperparathyroidism-jaw  ||| S:680 E:704 ||| JJ
tumor  ||| S:704 E:710 ||| NN
syndrome ||| S:710 E:718 ||| NN
,  ||| S:718 E:720 ||| ,
and  ||| S:720 E:724 ||| CC
familial  ||| S:724 E:733 ||| JJ
isolated  ||| S:733 E:742 ||| JJ
hyperparathyroidism ||| S:742 E:761 ||| NN
.  ||| S:761 E:763 ||| .
These  ||| S:763 E:769 ||| DT
syndromes  ||| S:769 E:779 ||| JJ
show  ||| S:779 E:784 ||| NN
mendelian  ||| S:784 E:794 ||| NN
inheritance  ||| S:794 E:806 ||| NN
patterns  ||| S:806 E:815 ||| NNS
and  ||| S:815 E:819 ||| CC
the  ||| S:819 E:823 ||| DT
main  ||| S:823 E:828 ||| JJ
genes  ||| S:828 E:834 ||| NNS
for  ||| S:834 E:838 ||| IN
most  ||| S:838 E:843 ||| JJS
of  ||| S:843 E:846 ||| IN
them  ||| S:846 E:851 ||| PRP
have  ||| S:851 E:856 ||| VBP
been  ||| S:856 E:861 ||| VBN
defined ||| S:861 E:868 ||| VBN
.  ||| S:868 E:870 ||| .
The  ||| S:870 E:874 ||| DT
classic  ||| S:874 E:882 ||| JJ
form  ||| S:882 E:887 ||| NN
of  ||| S:887 E:890 ||| IN
PHPT ||| S:890 E:894 ||| NNP
,  ||| S:894 E:896 ||| ,
which  ||| S:896 E:902 ||| WDT
presents  ||| S:902 E:911 ||| VBZ
with  ||| S:911 E:916 ||| IN
hypercalcemia ||| S:916 E:929 ||| NN
,  ||| S:929 E:931 ||| ,
kidney  ||| S:931 E:938 ||| NN
stones ||| S:938 E:944 ||| NNS
,  ||| S:944 E:946 ||| ,
and  ||| S:946 E:950 ||| CC
bone  ||| S:950 E:955 ||| NN
disease ||| S:955 E:962 ||| NN
,  ||| S:962 E:964 ||| ,
is  ||| S:964 E:967 ||| VBZ
no  ||| S:967 E:970 ||| RB
longer  ||| S:970 E:977 ||| RBR
common ||| S:977 E:983 ||| JJ
.  ||| S:983 E:985 ||| .
Currently ||| S:985 E:994 ||| RB
,  ||| S:994 E:996 ||| ,
there  ||| S:996 E:1002 ||| EX
is  ||| S:1002 E:1005 ||| VBZ
an  ||| S:1005 E:1008 ||| DT
increasing  ||| S:1008 E:1019 ||| JJ
interest  ||| S:1019 E:1028 ||| NN
in  ||| S:1028 E:1031 ||| IN
the  ||| S:1031 E:1035 ||| DT
subtle  ||| S:1035 E:1042 ||| JJ
manifestations  ||| S:1042 E:1057 ||| NNS
of  ||| S:1057 E:1060 ||| IN
PHPT ||| S:1060 E:1064 ||| NNP
,  ||| S:1064 E:1066 ||| ,
particularly  ||| S:1066 E:1079 ||| RB
the  ||| S:1079 E:1083 ||| DT
cardiovascular  ||| S:1083 E:1098 ||| JJ
and  ||| S:1098 E:1102 ||| CC
neuropsychiatric  ||| S:1102 E:1119 ||| JJ
manifestations ||| S:1119 E:1133 ||| NNS
.  ||| S:1133 E:1135 ||| .
Parathyroidectomy  ||| S:1135 E:1153 ||| NNP
is  ||| S:1153 E:1156 ||| VBZ
the  ||| S:1156 E:1160 ||| DT
definitive  ||| S:1160 E:1171 ||| JJ
cure  ||| S:1171 E:1176 ||| NN
for  ||| S:1176 E:1180 ||| IN
PHPT  ||| S:1180 E:1185 ||| NNP
even  ||| S:1185 E:1190 ||| RB
though  ||| S:1190 E:1197 ||| IN
patients  ||| S:1197 E:1206 ||| NNS
with  ||| S:1206 E:1211 ||| IN
the  ||| S:1211 E:1215 ||| DT
asymptomatic  ||| S:1215 E:1228 ||| JJ
form  ||| S:1228 E:1233 ||| NN
of  ||| S:1233 E:1236 ||| IN
the  ||| S:1236 E:1240 ||| DT
disease  ||| S:1240 E:1248 ||| NN
can  ||| S:1248 E:1252 ||| MD
be  ||| S:1252 E:1255 ||| VB
followed  ||| S:1255 E:1264 ||| VBN
conservatively ||| S:1264 E:1278 ||| RB
.  ||| S:1278 E:1280 ||| .
